Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 373

1.

Carbapenem-hydrolyzing oxacillinase in high resistant strains of Acinetobacter baumannii isolated from India.

Tiwari V, Kapil A, Moganty RR.

Microb Pathog. 2012 Aug;53(2):81-6. doi: 10.1016/j.micpath.2012.05.004.

PMID:
22610043
2.

Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.

Poirel L, Nordmann P.

Clin Microbiol Infect. 2006 Sep;12(9):826-36. Review.

4.

First report of the carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter baumannii isolates in Italy.

Bertini A, Giordano A, Varesi P, Villa L, Mancini C, Carattoli A.

Antimicrob Agents Chemother. 2006 Jun;50(6):2268-9. No abstract available.

5.

A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58.

Héritier C, Dubouix A, Poirel L, Marty N, Nordmann P.

J Antimicrob Chemother. 2005 Jan;55(1):115-8.

6.

OXA-235, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii.

Higgins PG, Pérez-Llarena FJ, Zander E, Fernández A, Bou G, Seifert H.

Antimicrob Agents Chemother. 2013 May;57(5):2121-6. doi: 10.1128/AAC.02413-12.

7.

OXA beta-lactamase-mediated carbapenem resistance in Acinetobacter baumannii.

Amudhan SM, Sekar U, Arunagiri K, Sekar B.

Indian J Med Microbiol. 2011 Jul-Sep;29(3):269-74. doi: 10.4103/0255-0857.83911.

8.

Gut colonization by multidrug-resistant and carbapenem-resistant Acinetobacter baumannii in neonates.

Roy S, Viswanathan R, Singh A, Das P, Basu S.

Eur J Clin Microbiol Infect Dis. 2010 Dec;29(12):1495-500. doi: 10.1007/s10096-010-1030-z.

PMID:
20730467
9.

Molecular characterisation of multiple drug-resistant Acinetobacter baumannii isolates in southern Taiwan.

Ben RJ, Yang MC, Hsueh JC, Shiang JC, Chien ST.

Int J Antimicrob Agents. 2011 Nov;38(5):403-8. doi: 10.1016/j.ijantimicag.2011.05.014.

PMID:
21871784
10.

Carbapenem-resistant Acinetobacter baumannii isolates from Tunisia producing the OXA-58-like carbapenem-hydrolyzing oxacillinase OXA-97.

Poirel L, Mansour W, Bouallegue O, Nordmann P.

Antimicrob Agents Chemother. 2008 May;52(5):1613-7. doi: 10.1128/AAC.00978-07.

11.

Conformational stability of OXA-51 β-lactamase explains its role in carbapenem resistance of Acinetobacter baumannii.

Tiwari V, Moganty RR.

J Biomol Struct Dyn. 2014;32(9):1406-20. doi: 10.1080/07391102.2013.819789.

PMID:
23879430
12.

OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii.

Poirel L, Marqué S, Héritier C, Segonds C, Chabanon G, Nordmann P.

Antimicrob Agents Chemother. 2005 Jan;49(1):202-8.

13.

OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii.

Higgins PG, Poirel L, Lehmann M, Nordmann P, Seifert H.

Antimicrob Agents Chemother. 2009 Dec;53(12):5035-8. doi: 10.1128/AAC.00856-09.

14.

Characterization of the carbapenem-hydrolyzing oxacillinase oxa-58 in an Acinetobacter genospecies 3 clinical isolate.

Marti S, Sánchez-Céspedes J, Blasco MD, Ruiz M, Espinal P, Alba V, Fernández-Cuenca F, Pascual A, Vila J.

Antimicrob Agents Chemother. 2008 Aug;52(8):2955-8. doi: 10.1128/AAC.00072-08.

15.

[Dissemination of IMP-1 and OXA type beta-lactamase in carbapenem-resistant Acinetobacter baumannii].

Sung JY, Kwon KC, Park JW, Kim YS, Kim JM, Shin KS, Kim JW, Ko CS, Shin SY, Song JH, Koo SH.

Korean J Lab Med. 2008 Feb;28(1):16-23. doi: 10.3343/kjlm.2008.28.1.16. Korean.

16.

Multiple carbapenem hydrolyzing genes in clinical isolates of Acinetobacter baumannii.

Niranjan DK, Singh NP, Manchanda V, Rai S, Kaur IR.

Indian J Med Microbiol. 2013 Jul-Sep;31(3):237-41. doi: 10.4103/0255-0857.115626.

17.
18.

Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii.

Héritier C, Poirel L, Lambert T, Nordmann P.

Antimicrob Agents Chemother. 2005 Aug;49(8):3198-202.

19.

Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii.

Héritier C, Poirel L, Fournier PE, Claverie JM, Raoult D, Nordmann P.

Antimicrob Agents Chemother. 2005 Oct;49(10):4174-9.

20.

Molecular mechanisms associated with nosocomial carbapenem-resistant Acinetobacter baumannii in Mexico.

Alcántar-Curiel MD, García-Torres LF, González-Chávez MI, Morfín-Otero R, Gayosso-Vázquez C, Jarillo-Quijada MD, Fernández-Vázquez JL, Giono-Cerezo S, Rodríguez-Noriega E, Santos-Preciado JI.

Arch Med Res. 2014 Oct;45(7):553-60. doi: 10.1016/j.arcmed.2014.10.006.

PMID:
25450581
Items per page

Supplemental Content

Support Center